Old Web
English
Sign In
Acemap
>
authorDetail
>
H. Serajuddin
H. Serajuddin
Angiogenesis inhibitor
Glioblastoma
VEGF receptors
Neovascularization
Medicine
2
Papers
207
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I/II trial of PTK787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor, in combination with either temozolomide or lomustine for patients with recurrent glioblastoma multiforme (GBM)
2004
Journal of Clinical Oncology
David A. Reardon
Henry S. Friedman
W. K.A. Yung
M Brada
Charles A. Conrad
James M. Provenzale
E. Jackson
H. Serajuddin
B. Chen
D. Laurent
Show All
Source
Cite
Save
Citations (88)
A phase I/II trial of single-agent PTK 787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor, in patients with recurrent glioblastoma multiforme (GBM)
2004
Journal of Clinical Oncology
Charles A. Conrad
Henry S. Friedman
David A. Reardon
James M. Provenzale
E. Jackson
H. Serajuddin
D. Laurent
B. Chen
W. K.A. Yung
Show All
Source
Cite
Save
Citations (119)
1